SCHEMBL4610147

SCHEMBL4610147

Brc1ccc(CCN2CCCC2)nc1

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 5/20 0.62
CYP1A2 P05177 2/20 0.60
CYP2D6 P10635 1/20 0.60
L3MBTL1 Q9Y468 3/20 0.44
LTA4H P09960 2/20 0.44
ATM Q13315 1/20 0.44
PTGS2 P35354 1/20 0.44
EPHX2 P34913 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
CYP3A4 P08684 1/20 0.42
SIGMAR1 Q99720 2/20 0.42
SLC6A3 Q01959 1/20 0.42
MBTD1 Q05BQ5 1/20 0.41
L3MBTL3 Q96JM7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12726995 0.90 HRH3 (0.51) HRH3CYP1A2CYP2D6L3MBTL1LTA4H
SCHEMBL31436872 0.87 HRH3 (0.51) HRH3CYP1A2CYP2D6TDP1SIGMAR1
SCHEMBL21813123 0.85 TSHR (0.50) HRH3CYP1A2CYP2D6SIGMAR1
SCHEMBL1881035 0.82 HRH3 (0.53) HRH3CYP1A2CYP2D6LTA4HTDP1
SCHEMBL17863636 0.82 HRH3 (0.43) HRH3CYP1A2CYP2D6ATMEPHX2
SCHEMBL1873045 0.81 HRH3 (0.55) HRH3CYP1A2CYP2D6L3MBTL1LTA4H
SCHEMBL2327396 0.80 DPP7 (0.49) HRH3CYP1A2CYP2D6L3MBTL1LTA4H
SCHEMBL82422 0.79 HRH3 (0.67) HRH3CYP1A2CYP2D6L3MBTL1EPHX2
SCHEMBL19313504 0.79 HRH3 (0.62) HRH3CYP1A2CYP2D6L3MBTL1LTA4H
SCHEMBL25353895 0.79 ATM (0.51) HRH3CYP1A2CYP2D6L3MBTL1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1948605-A2 MODULATORS OF THE H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2008-07-30 EP disclosed
WO-2007061741-A2 MODULATORS OF THE H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-05-31 WO disclosed